MASS on Nasdaq
908 Devices Inc.
Technology company.1
$11.95 up 0.12 (1.01%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 18, 2026.
Overview
Compare with Harvard Bioscience, RAPID MICRO BIOSYSTEMS, INC. or EyePoint Pharmaceuticals, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
50.6%Gross margin5
-70.1%Operating margin5
34.7%Net margin5
17.7%Revenue growth, 20255
13.6%Return on equity5
-$24.6MFree cash flow5
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Device Sales brought in 65% of the revenue 908 Devices Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Device Sales | $31.7M | $36.7M |
| Recurring | $15.9M | $19.4M |
| Contract | $132.0K | $117.0K |
Regions
United States brought in 73% of the revenue 908 Devices Inc. broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| United States | $35.6M | $41.2M |
| EMEA | $9.1M | $10.4M |
| Asia Pacific | $2.1M | $3.0M |
| Americas other | $863.0K | $1.5M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue27¢$27.8M
- Research and development15¢$15.6M
- Selling, general and admin38¢$38.5M
- Income tax0¢$66.0K
- Profit19¢$19.5M
Out of $56.2M in revenue.5
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $56.2M | $47.7M |
| Cost of revenue | $27.8M | $23.2M |
| Gross profit | $28.4M | $24.5M |
| Research and development | $15.6M | $15.0M |
| Selling, general and administrative | $38.5M | $39.5M |
| Change in fair value of contingent consideration | $13.7M | -$13.2M |
| Goodwill impairment | $40.7M | |
| Total operating expenses | $67.8M | $81.9M |
| Loss from continuing operations | -$39.4M | -$57.4M |
| Interest income | $4.1M | $4.5M |
| Income from transition services agreement, net | $2.3M | |
| Other expense, net | -$346.0K | -$241.0K |
| Total other income, net | $6.1M | $4.3M |
| Loss from operations before income taxes | -$33.3M | -$53.1M |
| Income tax expense | $66.0K | |
| Net loss from continuing operations | -$33.3M | -$53.1M |
| Net income (loss) from discontinued operations, net of tax | $52.8M | -$19.1M |
| Net income (loss) attributable to common stockholders | $19.5M | -$72.2M |
| Net loss from continuing operations per share attributable to common stockholders, basic | -$1 | -$2 |
| Net loss from continuing operations per share attributable to common stockholders, diluted | -$1 | -$2 |
| Net income (loss) from discontinued operations per share attributable to common stockholders, basic | $1 | -$1 |
| Net income (loss) from discontinued operations per share attributable to common stockholders, diluted | $1 | -$1 |
| Net income (loss) per share attributable to common stockholders, basic | $0.54 | -$2.12 |
| Net income (loss) per share attributable to common stockholders, diluted | $0.54 | -$2.12 |
| Weighted average common shares outstanding, basic | 35.9M shares | 34.1M shares |
| Weighted average common shares outstanding, diluted | 35.9M shares | 34.1M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2020-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $70.5M | $44.0M | ||
| Cash and cash equivalents from continuing operations | $43.4M | |||
| Marketable securities | $42.5M | $25.6M | ||
| Accounts receivable, net of allowance for credit losses of $147 and $524 at December 31, 2025 and December 31, 2024 | $11.3M | $8.9M | ||
| Inventory | $13.0M | $10.9M | ||
| Prepaid expenses and other current assets | $7.3M | $4.2M | ||
| Current assets of discontinued operations | $10.2M | |||
| Total current assets | $144.6M | $103.1M | ||
| Operating lease, right-of-use assets | $4.4M | $3.8M | ||
| Property and equipment, net | $4.2M | $1.6M | ||
| Intangible assets, net | $36.4M | $38.7M | ||
| Other long-term assets | $471.0K | $511.0K | ||
| Non-current assets of discontinued operations | $11.8M | |||
| Total assets | $190.1M | $159.5M | ||
| Accounts payable | $1.6M | $1.4M | ||
| Accrued expenses | $6.8M | $7.2M | ||
| Deferred revenue | $8.9M | $10.4M | ||
| Operating lease liabilities | $681.0K | $1.5M | ||
| Contingent consideration | $16.0M | |||
| Current liabilities of discontinued operations | $4.7M | |||
| Total current liabilities | $34.1M | $25.1M | ||
| Operating lease liabilities, net of current portion | $3.9M | $2.6M | ||
| Deferred revenue, net of current portion | $8.3M | $10.2M | ||
| Contingent consideration, net of current portion | $2.3M | |||
| Other long-term liabilities | $30.0K | |||
| Non-current liabilities of discontinued operations | $4.6M | |||
| Total liabilities | $46.4M | $44.9M | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 36,321,866 shares and 35,098,493 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $36.0K | $35.0K | ||
| Additional paid-in capital | $366.9M | $356.2M | ||
| Accumulated other comprehensive income | $54.0K | $1.1M | ||
| Accumulated deficit | -$223.3M | -$242.8M | ||
| Total stockholders' equity | $143.7M | $114.6M | $165.5M | |
| Total liabilities and stockholders' equity | $190.1M | $159.5M | ||
| Allowance for credit losses | $147.0K | $524.0K | $389.0K | |
| Preferred stock, par value | $0.00 | $0.00 | $0.00 | |
| Preferred stock, shares authorized | 5.0M shares | 5.0M shares | 5.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Common stock, par value | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 100.0M shares | 100.0M shares | 100.0M shares | |
| Common stock, shares issued | 36.3M shares | 35.1M shares | ||
| Common stock, shares outstanding | 36.3M shares | 35.1M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2020-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $70.5M | $44.0M | ||
| Cash and cash equivalents from continuing operations | $43.4M | |||
| Marketable securities | $42.5M | $25.6M | ||
| Accounts receivable, net of allowance for credit losses of $147 and $524 at December 31, 2025 and December 31, 2024 | $11.3M | $8.9M | ||
| Inventory | $13.0M | $10.9M | ||
| Prepaid expenses and other current assets | $7.3M | $4.2M | ||
| Current assets of discontinued operations | $10.2M | |||
| Total current assets | $144.6M | $103.1M | ||
| Operating lease, right-of-use assets | $4.4M | $3.8M | ||
| Property and equipment, net | $4.2M | $1.6M | ||
| Intangible assets, net | $36.4M | $38.7M | ||
| Other long-term assets | $471.0K | $511.0K | ||
| Non-current assets of discontinued operations | $11.8M | |||
| Total assets | $190.1M | $159.5M | ||
| Accounts payable | $1.6M | $1.4M | ||
| Accrued expenses | $6.8M | $7.2M | ||
| Deferred revenue | $8.9M | $10.4M | ||
| Operating lease liabilities | $681.0K | $1.5M | ||
| Contingent consideration | $16.0M | |||
| Current liabilities of discontinued operations | $4.7M | |||
| Total current liabilities | $34.1M | $25.1M | ||
| Operating lease liabilities, net of current portion | $3.9M | $2.6M | ||
| Deferred revenue, net of current portion | $8.3M | $10.2M | ||
| Contingent consideration, net of current portion | $2.3M | |||
| Other long-term liabilities | $30.0K | |||
| Non-current liabilities of discontinued operations | $4.6M | |||
| Total liabilities | $46.4M | $44.9M | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 36,321,866 shares and 35,098,493 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $36.0K | $35.0K | ||
| Additional paid-in capital | $366.9M | $356.2M | ||
| Accumulated other comprehensive income | $54.0K | $1.1M | ||
| Accumulated deficit | -$223.3M | -$242.8M | ||
| Total stockholders' equity | $143.7M | $114.6M | $165.5M | |
| Total liabilities and stockholders' equity | $190.1M | $159.5M | ||
| Allowance for credit losses | $147.0K | $524.0K | $389.0K | |
| Preferred stock, par value | $0.00 | $0.00 | $0.00 | |
| Preferred stock, shares authorized | 5.0M shares | 5.0M shares | 5.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Common stock, par value | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 100.0M shares | 100.0M shares | 100.0M shares | |
| Common stock, shares issued | 36.3M shares | 35.1M shares | ||
| Common stock, shares outstanding | 36.3M shares | 35.1M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | $19.5M | -$72.2M |
| Goodwill impairment | $40.7M | |
| Depreciation and amortization expense | $4.5M | $4.7M |
| Stock-based compensation expense | $9.8M | $11.8M |
| Provision for inventory obsolescence | $513.0K | $653.0K |
| Net amortization of premiums and accretion of discounts on marketable securities | -$637.0K | $13.0K |
| Loss on disposal of property and equipment | $133.0K | $54.0K |
| Gain on sale of Desktop Portfolio, net of transaction costs | -$55.9M | |
| Provision for credit losses | $176.0K | |
| Change in fair value of contingent consideration | $13.7M | -$13.2M |
| Deferred income tax | -$283.0K | |
| Accounts receivable, net | $220.0K | -$2.9M |
| Inventory | -$3.7M | -$1.7M |
| Prepaid expenses and other current assets | -$3.0M | -$445.0K |
| Other long-term assets | $211.0K | $559.0K |
| Accounts payable and accrued expenses | -$5.9M | $2.3M |
| Deferred revenue | -$3.2M | -$368.0K |
| Right-of-use operating lease assets | $1.7M | $2.0M |
| Operating lease liabilities | -$1.7M | -$2.1M |
| Net cash used in operating activities | -$23.7M | -$30.2M |
| Purchases of property and equipment | -$955.0K | -$602.0K |
| Purchases of marketable securities | -$64.0M | -$55.5M |
| Acquisition of businesses, net of cash acquired | -$2.0M | -$44.8M |
| Proceeds from sale of Desktop Portfolio | $69.9M | |
| Proceeds from maturities of marketable securities | $47.8M | $54.6M |
| Net cash provided by (used in) investing activities | $50.7M | -$46.3M |
| Payments for withholding taxes on vested awards | -$833.0K | -$1.1M |
| Proceeds from issuance of common stock | $864.0K | $1.1M |
| Payments for contingent consideration | -$728.0K | -$417.0K |
| Net cash used in financing activities | -$697.0K | -$376.0K |
| Effect of foreign exchange rate changes on cash and cash equivalents | $27.0K | -$65.0K |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $26.4M | -$77.0M |
| Transfers of inventory to property and equipment | $983.0K | $1.2M |
| Fair value of common stock issued for acquisition of RedWave Technology | $8.6M | |
| Cash (received) paid for income tax | -$66.0K | $184.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led 908 Devices Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
2025
- Chief executive officerKevin J. Knopp Dec 17, 2020 to now12
- PresidentKevin J. Knopp Dec 17, 2020 to now12
- Chief financial officerJoseph H. Griffith Iv. Dec 17, 2020 to now13
Board members and other officers (17)
- SVP, Products and ProductionKevin J. McCallion Mar 4, 2026 to now14
- Chief Bus. & Strategy OfficerKolawole A. Otitoju Apr 22, 2026 to now15
- VP, Product Management & MktgMaura Fitzpatrick May 9, 2022 to Feb 3, 202316
- VP, Corporate DevelopmentNicolas Barthelemy Jun 25, 2021 to Jun 25, 202117
- Vice President, GovernmentJohn Kenneweg Dec 17, 2020 to now18
- Vice President, CommercialTrent A. Basarsky Dec 17, 2020 to Apr 28, 202219
- Board memberBrandi C. Vann Aug 18, 2025 to now20
- Board memberMichele M. Leonhart Jun 26, 2024 to now21
- Board memberAnthony Hunt Mar 4, 2022 to now22
- Board memberFenel M. Eloi Mar 2, 2021 to now23
- Board memberJeffrey P. George Mar 2, 2021 to now24
- Board memberE. Kevin Hrusovsky Dec 17, 2020 to now25
- Board memberKeith Crandell Dec 17, 2020 to now26
- Board memberKevin J. Knopp Dec 17, 2020 to now12
- Board memberMark Spoto Dec 17, 2020 to now27
- Board memberNicolas Barthelemy Dec 17, 2020 to Jun 17, 202228
- Board memberSharon Kedar Dec 17, 2020 to Dec 22, 202029
Timeline
- Dec 17, 2020New chief executive Kevin J. Knopp becomes CEO12
Filings
374 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 39 major events, 216 insider forms, 43 large holders, 56 other. The latest 20:
- Oct 9, 20264 EDGAR
- Oct 8, 20264 EDGAR
- Oct 6, 2026144 EDGAR
- Oct 1, 20264 PRIMARY DOCUMENT EDGAR
- Sep 25, 20264 PRIMARY DOCUMENT EDGAR
- Sep 17, 20264 EDGAR
- Sep 15, 2026144 EDGAR
- Sep 4, 20264 EDGAR
- Aug 27, 20264 EDGAR
- Aug 25, 2026144 EDGAR
- Aug 24, 20264 PRIMARY DOCUMENT EDGAR
- Aug 17, 20264 EDGAR
- Aug 17, 2026144 EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 12, 20264 EDGAR
- Aug 12, 20264 EDGAR
- Aug 11, 2026144 EDGAR
- Aug 11, 202610-Q EDGAR
The 374 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 43 such filings since October 2021, the latest 10:
- Aug 14, 2026SCHEDULE 13G/A
- Aug 14, 2026SCHEDULE 13G/A
- Aug 14, 2026SCHEDULE 13G/A
- Jul 27, 2026SCHEDULE 13G
- Jun 5, 2026SCHEDULE 13G/A
- May 15, 2026SCHEDULE 13G/A
- Feb 17, 2026SCHEDULE 13G/A
- Feb 9, 2026SCHEDULE 13G
- Dec 5, 2025SCHEDULE 13G/A
- Nov 14, 2025SCHEDULE 13G
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Links
- Website908devices.com1
- X (Twitter)x.com/908devices1
- Facebookwww.facebook.com/908Devices1
- LinkedInwww.linkedin.com/company/908-devices1
- WikidataQ120997607
- SEC EDGARCIK 1555279
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1Wikidata908 Devices Inc. on Wikidata
- 2
- 3Yahoo FinanceMASS quote
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20SEC EDGARBrandi C. Vann, Board member
- 21SEC EDGARMichele M. Leonhart, Board member
- 22SEC EDGARAnthony Hunt, Board member
- 23SEC EDGARFenel M. Eloi, Board member
- 24SEC EDGARJeffrey P. George, Board member
- 25SEC EDGARE. Kevin Hrusovsky, Board member
- 26SEC EDGARKeith Crandell, Board member
- 27SEC EDGARMark Spoto, Board member
- 28SEC EDGARNicolas Barthelemy, Board member
- 29SEC EDGARSharon Kedar, Board member